The present invention relates to pyrazolotriazines according to formula (I) ##STR1##

and stereoisomers, isomers and salts thereof wherein R1-R5 are selected from certain alkyl, aryl and heteroaryl species as defined in the specification wherein all of the compounds are useful as CRF antagonists and are thus useful in the treatment of neurological disorders as well as a multitude of other CRF associated diseases or conditions.

 
Web www.patentalert.com

< Silanol enzyme inhibitors

< Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

> Thyroid receptor ligands

> Protective antigen of Epstein Barr Virus

~ 00218